Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDMirum Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 5 | -$0.55 | -$0.22 | -$0.37 |
| Q2 2026 | 4 | -$1.41 | -$0.39 | -$0.74 |
| Q3 2026 | 4 | -$1.24 | -$0.20 | -$0.67 |
| Q4 2026 | 2 | -$0.78 | -$0.74 | -$0.76 |
| Q1 2027 | 2 | -$0.43 | -$0.41 | -$0.42 |
| Q2 2027 | 1 | -$0.36 | -$0.34 | -$0.35 |
| Q3 2027 | 1 | -$0.20 | -$0.19 | -$0.20 |
| Q4 2027 | 2 | -$0.02 | -$0.02 | -$0.02 |
Mirum Pharmaceuticals Inc Earnings Date And Information
Mirum Pharmaceuticals Inc last posted its earnings results on Wednesday, May 6th, 2026. The company reported $-13.43 earnings per share for the quarter, missing analysts' consensus estimates of $-0.4 by $13.03. The company had revenue of 159.88 M for the quarter and had revenue of 521.31 M for the year. Mirum Pharmaceuticals Inc has generated $0 earnings per share over the last year ($-0.47 diluted earnings per share) and currently has a price-to-earnings ratio of -7.92. Mirum Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Mirum Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2026 | Q1 2026 | -$0.40 | -$13.43 | -13.03 | $148.21 M | $159.88 M |
| 02/25/2026 | Q4 2025 | $0.02 | -$0.12 | -0.14 | $142.50 M | $148.93 M |
| 11/04/2025 | Q3 2025 | -$0.10 | $0.06 | 0.16 | $130.50 M | $133.01 M |
| 08/06/2025 | Q2 2025 | -$0.31 | -$0.12 | 0.19 | $108.11 M | $127.79 M |
| 05/07/2025 | Q1 2025 | -$0.39 | -$0.30 | 0.09 | $98.42 M | $111.59 M |
| 02/26/2025 | Q4 2024 | -$0.27 | -$0.49 | -0.22 | $96.61 M | $99.41 M |
| 11/12/2024 | Q3 2024 | -$0.45 | -$0.30 | 0.15 | $81.99 M | $90.38 M |
| 08/07/2024 | Q2 2024 | -$0.48 | -$0.52 | -0.04 | $75.03 M | $77.88 M |
| 05/08/2024 | Q1 2024 | -$0.40 | -$0.54 | -0.14 | $70.13 M | $69.22 M |
| 03/15/2024 | Q4 2023 | N/A | -$0.71 | N/A | N/A | $69.55 M |
| 11/02/2023 | Q3 2023 | -$0.64 | -$0.57 | 0.07 | N/A | $47.73 M |
| 08/07/2023 | Q2 2023 | N/A | -$1.94 | N/A | N/A | $37.50 M |
| 05/04/2023 | Q1 2023 | -$0.96 | -$0.80 | 0.16 | N/A | $31.60 M |
| 03/08/2023 | Q4 2022 | -$0.98 | -$0.99 | -0.01 | N/A | $27.91 M |
| 11/09/2022 | Q3 2022 | -$1.05 | -$1.02 | 0.03 | N/A | $18.78 M |
| 08/04/2022 | Q2 2022 | -$1.05 | -$0.84 | 0.21 | N/A | $17.48 M |
| 05/05/2022 | Q1 2022 | -$1.39 | -$1.17 | 0.22 | N/A | $12.89 M |
| 03/09/2022 | Q4 2021 | -$0.61 | $1.88 | 2.49 | N/A | $3.14 M |
| 11/15/2021 | Q3 2021 | -$1.63 | -$1.55 | 0.08 | N/A | $5.00 M |
| 08/05/2021 | Q2 2021 | -$0.41 | -$1.45 | -1.04 | N/A | $11.00 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Mirum Pharmaceuticals Inc Earnings: FAQ's
The conference call for Mirum Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Mirum Pharmaceuticals Inc's latest earnings report can be read online.
Mirum Pharmaceuticals Inc (:MIRM) has a recorded annual revenue of $521.31 M.
Mirum Pharmaceuticals Inc (:MIRM) has a recorded net income of $-23,363,000.Mirum Pharmaceuticals Inc has generated $-0.47 earnings per share over the last four quarters.
Mirum Pharmaceuticals Inc (:MIRM) has a price-to-earnings ratio of -7.92 and price/earnings-to-growth ratio is 0.